The earnings report, which is expected to be released on July 30, 2024, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower. Zacks Consensus Estimate Revenues are expected to be $4.01 billion, up 4.5% from the year-ago quarter. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial ...

Leidos (LDOS) closed at $148.96 in the latest trading session, marking a -0.64% move from the prior day. The stock trailed the S&P 500, which registered a daily gain of 0.28%. Meanwhile, the Dow gained 0.53%, and the Nasdaq, a tech-heavy index, added 0.4%. Investors will be eagerly watching for the performance of Leidos in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on July 30, 2024. It is anticipated that the company will report an EPS of $2.26, marking a 25.56% ri ...

By their very nature, these stocks carry above-average risk and volatility. Moreover, if a company's growth story is over or nearing its end, betting on it could lead to significant loss. Studies have shown that stocks with the best growth features consistently outperform the market. And returns are even better for stocks that possess the combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy). Earnings growth is arguably the most important factor, as stocks exhibiting exceptiona ...

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sellside) analysts often affect a stock's price, do they really matter? Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Leidos (LDOS) . Leidos currently has an average brokerage recommendation ( ...

"Leidos is at the forefront of advancing human spaceflight," said Liz Porter, president of Leidos Health & Civil sector. "From ensuring safe water for long-duration missions with our new Exploration Potable Water Dispenser to studying the impacts of radiation and microgravity, we are addressing some of the most critical challenges in space exploration." Leidos will provide analytical and physical processing for NASA missions and perform engineering, maintenance, and operations support. Leidos will also deve ...

Investors interested in Aerospace - Defense stocks are likely familiar with Leidos (LDOS) and Airbus Group (EADSY) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank is a proven strategy that targets companies with positive earnings estimate revision trend ...

"Transitioning North Dakota's legacy Medicaid systems to a modern system will help provide a better healthcare experience for patients, providers and administrators," said Liz Porter, Leidos Health & Civil Sector President. "Building on our strength of innovation and proven expertise in technology modernization, we look forward to delivering tailored solutions that empower data-driven decision making. This modernization project will help position North Dakota to embrace and harness future advancements." To ...

Investors interested in Aerospace - Defense stocks are likely familiar with Leidos (LDOS) and Airbus Group (EADSY) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores work to identify stoc ...

Though the strategy does not offer dramatic price appreciation, it is a major source of consistent income for investors in any market. In particular, focusing on the growth level in this strategy leads to higher returns. Stocks with a strong history of year-over-year dividend growth form a healthy portfolio, with a greater scope of capital appreciation, as opposed to simple dividend-paying stocks or those with high yields. Although these stocks do not necessarily have the highest yields, they have outperfor ...

Introduction PGPF This year, the LDOS stock has also taken a cue from upwardly revissd earnings guidance on various metrics, and enjoyed a stellar journey so far, for context, on a YTD So far so good, but we would choose not to get too carried away at this juncture, and would rather rate the stock as a HOLD LDOS's second-largest division- Health and Civil (which accounts for 30% of group revenue) has enjoyed a surprisingly resilient Q1, with revenue up by 19%, and operating income margins expanding by over ...